Resources

The following materials are provided by Aclaris Therapeutics, Inc., to use in your practice.

DOWNLOADS FOR
YOUR PRACTICE

ESKATA email templates

   

Use these email templates to let your patients know about the benefits of ESKATA or to communicate information about ESKATA-related events within your practice.

Before and after images

   

Use these images to personalize promotional tactics and show patient outcomes from real ESKATA treatments. Files are intended for promotional purposes only.

ESKATA logo

   

Download this logo to personalize ESKATA promotional tactics according to the needs of your practice. Files are intended for promotional purposes only.

ESKATA pen graphic

   

Download this image to personalize ESKATA promotional tactics according to the needs of your practice. Files are intended for promotional purposes only.

ESKATA packaging graphic

   

Download this image to personalize ESKATA promotional tactics according to the needs of your practice. Files are intended for promotional purposes only.

VIDEO DOWNLOADS

ESKATA TV commercial

   

Introduce ESKATA to your patients with this 60-second commercial that provides education on how ESKATA can help with raised SKs.

NewBeauty testimonial

   

To show your patients how ESKATA can help them put their best face forward, share this inspiring testimonial video produced in partnership with NewBeauty.

In-office video loop

   

If you have an in-office video player, download and play this video in your waiting area to increase patient awareness around raised SKs and ESKATA.

DOWNLOADS FOR
YOUR PATIENTS

Patient brochure and safety information

   

This brochure will help your patients understand raised SK as a disease state, as well as the efficacy and safety of ESKATA.

Patient reminder card

   

Distribute the patient reminder card after treatment to provide follow-up appointment dates and post-treatment protocol.

Spanish patient brochure and safety information

   

This brochure will help your Spanish- speaking patients understand raised SK as a disease state, as well as the efficacy and safety of ESKATA.

Frequently asked questions (FAQ)

ESKATA can be administered by physician or nonphysician healthcare providers.
Certification is not required prior to purchase or use, but it is recommended that healthcare providers review the application technique in the ESKATA Prescribing Information.
Application time will vary depending on the number of lesions treated with each applicator.
Prior to application of ESKATA, clean the seborrheic keratoses to be treated using an alcohol wipe. When treating seborrheic keratoses on the face, take appropriate actions to ensure that ESKATA will not come into contact with the eyes.
ESKATA does not require refrigeration or any other special storage. ESKATA needs to be stored at room temperature (68-77°F).
ESKATA has a shelf life of 2 years at room temperature (68-77°F). Once the applicator is activated, the product will be stable for 4 hours.

Order ESKATA now

INDICATIONS AND USAGE

ESKATA® (hydrogen peroxide) topical solution, 40% (w/w) is indicated for the treatment of seborrheic keratoses that are raised.

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

Do not apply ESKATA to the eyes or mucous membranes. Avoid treating seborrheic keratoses within the orbital rim. Direct contact with the eye can cause corneal injury (erosion, ulceration, perforation, and scarring), chemical conjunctivitis, eyelid edema, severe eye pain or permanent eye injury, including blindness. If accidental exposure occurs, flush with water for 15 to 30 minutes, initiate monitoring and further evaluation as appropriate.

Skin reactions occurred in the treatment area after application of ESKATA. Severe local skin reactions included erosion, ulceration, vesiculation and scarring. Do not re-treat until the skin has recovered from any reaction caused by the previous treatment.

MOST COMMON ADVERSE REACTIONS

The most common adverse reactions include erythema (99%), stinging (97%), edema (91%), scaling (90%), crusting (81%), and pruritus (58%).

CONTRAINDICATIONS

None.

DOSAGE AND ADMINISTRATION

ESKATA is to be administered by a healthcare provider. For topical use only. Not for oral, ophthalmic, or intravaginal use. Not for open or infected seborrheic keratoses.

Please see accompanying full Prescribing Information for ESKATA® (hydrogen peroxide) topical solution, 40% (w/w).